Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 862 | 237 | 201 | 63 | 0 |
| Cost of Goods | 45 | 45 | 45 | 45 | N/A |
| Gross Profit | 817 | 192 | 156 | 18 | N/A |
| Operating Expenses | 2,850 | 2,715 | 4,722 | 4,120 | 2,162 |
| Operating Income | -1,988 | -2,477 | -4,521 | -4,057 | -2,162 |
| Interest Expense | -105 | 63 | 68 | 72 | -71 |
| Other Income | 260 | -359 | 254 | 708 | -921 |
| Pre-tax Income | -1,623 | -2,899 | -4,335 | -3,421 | -3,012 |
| Net Income Continuous | -1,623 | -2,899 | -4,335 | -3,421 | -3,012 |
| Minority Interests | 962 | -159 | -800 | -363 | -101 |
| Net Income | $-2,585 | $-2,739 | $-3,535 | $-3,058 | $-2,911 |
| EPS Basic Total Ops | 0.05 | -0.58 | -1.17 | -1.11 | -5.35 |
| EPS Basic Continuous Ops | -0.01 | -0.61 | -1.17 | -1.11 | -5.44 |
| EPS Diluted Total Ops | 0.05 | -0.58 | -1.17 | -1.11 | -5.35 |
| EPS Diluted Continuous Ops | -0.01 | -0.61 | -1.17 | -1.11 | -5.44 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.58 | -1.17 | -1.11 | N/A |
| EBITDA(a) | $-1,693 | $-2,124 | $-3,838 | $-3,662 | $-1,846 |